Gerald W. Neuberg

2.6k total citations · 1 hit paper
26 papers, 1.9k citations indexed

About

Gerald W. Neuberg is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gerald W. Neuberg has authored 26 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 4 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gerald W. Neuberg's work include Heart Failure Treatment and Management (10 papers), Cardiac electrophysiology and arrhythmias (5 papers) and Receptor Mechanisms and Signaling (4 papers). Gerald W. Neuberg is often cited by papers focused on Heart Failure Treatment and Management (10 papers), Cardiac electrophysiology and arrhythmias (5 papers) and Receptor Mechanisms and Signaling (4 papers). Gerald W. Neuberg collaborates with scholars based in United States. Gerald W. Neuberg's co-authors include Milton Packer, Peter E. Carson, Alan B. Miller, Robert N. Belkin, J Wertheimer, David J. Frid, Milton L. Pressler, Anne B. Cropp, Christopher M. O’Connor and Jalal K. Ghali and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Gerald W. Neuberg

25 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Amlodipine on Morbidity and Mortality in Severe Chronic Heart Failure

1996 808 citations Milton Packer, Christopher M. O’Connor et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gerald W. Neuberg United States	13	1.6k	215	178	168	154	26	1.9k
Terry L. Holcslaw United States	12	1.6k 1.0×	196 0.9×	158 0.9×	152 0.9×	154 1.0×	27	2.1k
Domenico Scrutinio Italy	22	1.2k 0.7×	195 0.9×	171 1.0×	331 2.0×	97 0.6×	105	1.9k
Ronald S. Freudenberger United States	26	1.4k 0.9×	190 0.9×	259 1.5×	326 1.9×	182 1.2×	74	2.2k
Pieter A. de Graeff Netherlands	24	1.3k 0.8×	183 0.9×	213 1.2×	199 1.2×	350 2.3×	63	2.1k
Marcelo C. Shibata Canada	13	1.7k 1.1×	134 0.6×	98 0.6×	168 1.0×	256 1.7×	20	2.1k
Christopher J. O’Donnell United States	10	1.4k 0.9×	111 0.5×	248 1.4×	207 1.2×	350 2.3×	14	2.2k
B.M. Massie United States	12	921 0.6×	176 0.8×	113 0.6×	106 0.6×	67 0.4×	22	1.1k
H. J. Dargie United Kingdom	18	1.3k 0.8×	203 0.9×	143 0.8×	222 1.3×	80 0.5×	32	1.8k
Francesco Orso Italy	15	1.1k 0.7×	401 1.9×	94 0.5×	209 1.2×	170 1.1×	63	1.5k
Manolis S. Kallistratos Greece	17	768 0.5×	142 0.7×	123 0.7×	195 1.2×	180 1.2×	66	1.4k

Countries citing papers authored by Gerald W. Neuberg

Since Specialization

Citations

This map shows the geographic impact of Gerald W. Neuberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald W. Neuberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald W. Neuberg more than expected).

Fields of papers citing papers by Gerald W. Neuberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald W. Neuberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald W. Neuberg. The network helps show where Gerald W. Neuberg may publish in the future.

Co-authorship network of co-authors of Gerald W. Neuberg

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald W. Neuberg. A scholar is included among the top collaborators of Gerald W. Neuberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald W. Neuberg. Gerald W. Neuberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Prager, Kenneth, et al.. (2021). Ethical Framework to Guide Decisions of Treatment Over Objection. Journal of the American College of Surgeons. 233(4). 508–516. 7 indexed citations

Brener, Michael I., Osman R. Sayan, Robert M. Minutello, et al.. (2019). An Updated Healthcare System-Wide Clinical Pathway for Managing Patients With Chest Pain and Acute Coronary Syndromes. Critical Pathways in Cardiology A Journal of Evidence-Based Medicine. 18(4). 167–175. 7 indexed citations

Wu, Audrey H., Wayne C. Levy, Kathleen B. Welch, et al.. (2013). Association Between Bilirubin and Mode of Death in Severe Systolic Heart Failure. The American Journal of Cardiology. 111(8). 1192–1197. 14 indexed citations

Galper, Benjamin Z., Michael P. Collins, Osman R. Sayan, et al.. (2011). Updating the Chest Pain Algorithm. Critical Pathways in Cardiology A Journal of Evidence-Based Medicine. 10(1). 9–16. 6 indexed citations

Neuberg, Gerald W.. (2009). The Cost of End-of-Life Care. Circulation Cardiovascular Quality and Outcomes. 2(2). 127–133. 26 indexed citations

Esposito, Francesca, Michael P. Collins, Osman R. Sayan, et al.. (2008). Updating the Chest Pain Algorithm. Critical Pathways in Cardiology A Journal of Evidence-Based Medicine. 7(4). 211–222. 6 indexed citations

Neuberg, Gerald W., Alan B. Miller, Chris O’Connor, et al.. (2002). Diuretic resistance predicts mortality in patients with advanced heart failure. American Heart Journal. 144(1). 31–38. 286 indexed citations

Carson, Peter, Christopher M. O’Connor, Alan B. Miller, et al.. (2000). Circadian rhythm and sudden death in heart failure. Journal of the American College of Cardiology. 36(2). 541–546. 45 indexed citations

Udelson, James E., C. Andrew DeAbate, Michael Berk, et al.. (2000). Effects of amlodipine on exercise tolerance, quality of life, and left ventricular function in patients with heart failure from left ventricular systolic dysfunction. American Heart Journal. 139(3). 503–510. 37 indexed citations

10.

O’Connor, Christopher M., Peter E. Carson, Alan B. Miller, et al.. (1998). Effect of amlodipine on mode of death among patients with advanced heart failure in the praise trial. The American Journal of Cardiology. 82(7). 881–887. 63 indexed citations

11.

Pressler, Milton L., Peter E. Carson, Alan B. Miller, et al.. (1996). Safety of amiodipine in severe heart failure: Reduction of sudden death in non-ischemic heart disease. Journal of the American College of Cardiology. 27(2). 281–281. 3 indexed citations

12.

Carson, Peter, Milton L. Pressler, Alan B. Miller, et al.. (1996). Circadian rhythm and sudden death in heart failure: Results from praise. Journal of the American College of Cardiology. 27(2). 280–280. 1 indexed citations

13.

Packer, Milton, Christopher M. O’Connor, Jalal K. Ghali, et al.. (1996). Effect of Amlodipine on Morbidity and Mortality in Severe Chronic Heart Failure. New England Journal of Medicine. 335(15). 1107–1114. 808 indexed citations breakdown →

14.

Horn, Evelyn M., Marrick Kukin, Gerald W. Neuberg, et al.. (1995). Lymphocyte G proteins reflect response to treatment in congestive heart failure. American Heart Journal. 129(1). 98–106. 5 indexed citations

15.

Krum, Henry, Jonathan Sackner‐Bernstein, Rochelle L. Goldsmith, et al.. (1995). Double-Blind, Placebo-Controlled Study of the Long-term Efficacy of Carvedilol in Patients With Severe Chronic Heart Failure. Circulation. 92(6). 1499–1506. 285 indexed citations

16.

Massie, Barry M., Martin R. Berk, Susan C. Brozena, et al.. (1993). Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET).. Circulation. 88(2). 492–501. 78 indexed citations

17.

Neuberg, Gerald W., Marrick Kukin, Joshua Penn, et al.. (1991). Hemodynamic effects of renin inhibition by enalkiren in chronic congestive heart failure. The American Journal of Cardiology. 67(1). 63–66. 32 indexed citations

18.

Kukin, Marrick, Paul Kessler, Stephen S. Gottlieb, et al.. (1991). Can acute hemodynamic studies in heart failure be used to predict the optimal dose of a new drug during long-term therapy?. Journal of the American College of Cardiology. 17(2). A163–A163. 1 indexed citations

19.

Neuberg, Gerald W., Marrick Kukin, Joshua Penn, et al.. (1990). Renin inhibition (but not plasma renin activity) predicts the response to converting-enzyme inhibitors in chronic heart failure. Journal of the American College of Cardiology. 15(2). A172–A172. 1 indexed citations

20.

Neuberg, Gerald W.. (1988). Cardiopulmonary Exercise Testing. Archives of Internal Medicine. 148(10). 2221–2221. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact